WuXi XDC, a contract research, development, and manufacturing organization (CRDMO) headquartered in China, recently tapped Shreiner MediPharm to support a clinical trial for an ADC drug that required a reliable label solution.
 
A light-sensitive active ingredient filled into vials as a lyophilized powder needed to be effectively protected against external influences. WuXi XDC found the solution through cooperation with Schreiner MediPharm by implementing a Light-Protect-Label that perfectly met the specific customer requirements.
 
Schreiner MediPharm developed a solution with integrated UV and light protection that is ideally suited to transparent vials. The opaque label completely wraps around the container and offers optimal light protection. At the same time, it supports a dependable and safe conduct of the clinical trial by reliably blinding the investigational drugs. A resealable inspection window enables an unadulterated view of the vial content. The window is crucial for inspecting the condition and color of the reconstituted lyophilizate before it is administered, thus ensuring the efficacy of the medication.
 
The label-integrated light protection solution from Schreiner MediPharm was customized to suit the specific application and respective container. Schreiner MediPharm drew upon its expertise in materials, adhesives, and printing techniques, as well as comprehensive tests of light protection properties. Hence WuXi XDC benefitted from an efficient, multifunctional solution combining protection of the light-sensitive active ingredient with reliable blinding as part of a clinical trial.